Cite
Sun Z, Meng P, Su C, et al. PCC-0105002, a novel small molecule inhibitor of PSD95-nNOS protein-protein interactions, attenuates neuropathic pain and corrects motor disorder associated with neuropathic pain model. Toxicol Appl Pharmacol. 2021;429:115698doi: 10.1016/j.taap.2021.115698.
Sun, Z., Meng, P., Su, C., Ji, S., Gao, Y., Wang, H., Tian, J., & Li, C. (2021). PCC-0105002, a novel small molecule inhibitor of PSD95-nNOS protein-protein interactions, attenuates neuropathic pain and corrects motor disorder associated with neuropathic pain model. Toxicology and applied pharmacology, 429115698. https://doi.org/10.1016/j.taap.2021.115698
Sun, Zhihong, et al. "PCC-0105002, a novel small molecule inhibitor of PSD95-nNOS protein-protein interactions, attenuates neuropathic pain and corrects motor disorder associated with neuropathic pain model." Toxicology and applied pharmacology vol. 429 (2021): 115698. doi: https://doi.org/10.1016/j.taap.2021.115698
Sun Z, Meng P, Su C, Ji S, Gao Y, Wang H, Tian J, Li C. PCC-0105002, a novel small molecule inhibitor of PSD95-nNOS protein-protein interactions, attenuates neuropathic pain and corrects motor disorder associated with neuropathic pain model. Toxicol Appl Pharmacol. 2021 Oct 15;429:115698. doi: 10.1016/j.taap.2021.115698. Epub 2021 Aug 21. PMID: 34428447.
Copy
Download .nbib